Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (Q38762779)

6 September 2017

title

Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy (English)

1 reference

6 September 2017

Nafees Muhammad

1

1 reference

6 September 2017

Xiaoyong Wang

2

1 reference

6 September 2017

Kun Wang

3

1 reference

6 September 2017

Chengcheng Zhu

4

1 reference

6 September 2017

Zhenzhu Zhu

5

1 reference

6 September 2017

Yang Jiao

6

1 reference

6 September 2017

Zijian Guo

7

1 reference

6 September 2017

language of work or name

English

0 references

publication date

23 June 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

45

1 reference

6 September 2017

issue

33

1 reference

6 September 2017

page(s)

13169-13178

1 reference

Metal-based anticancer chemotherapeutic agents

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Targeting and delivery of platinum-based anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Metal-based antitumour drugs in the post-genomic era: what comes next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Polymeric biomaterials for the delivery of platinum-based anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Basis for design and development of platinum(IV) anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(IV) prodrug with unique mode of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Targeting mitochondria by α-tocopheryl succinate kills neuroblastoma cells irrespective of MycN oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

The applications of Vitamin E TPGS in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Drug targeting to the diseased liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Galactosylated polymeric carriers for liver targeting of sorafenib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

A review of glycosylated carriers for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Current advances in research and clinical applications of PLGA-based nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Concepts and practices used to develop functional PLGA-based nanoparticulate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Contrasting effects of α-tocopheryl succinate on cisplatin- and etoposide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

The effect of ligand lipophilicity on the nanoparticle encapsulation of Pt(IV) prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Apoptosis and necrosis: detection, discrimination and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Chemotherapeutic approaches for targeting cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Pt(IV) complexes as prodrugs for cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

α-Tocopheryloxyacetic acid is superior to α-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Synthetic polymeric nanoparticles by nanoprecipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC6DT01434H

21 January 2018

Identifiers

DOI

10.1039/C6DT01434H

1 reference

6 September 2017

1 reference